New Efficient Catheter-Based System for Myocardial Gene Delivery

Background—Manipulating gene expression in the failing heart has therapeutic promise, but until now efficient and homogeneous cardiac gene delivery has required an open-chest approach. This study examines the hypothesis that vector delivery promoted by echo contrast microbubbles will be maximized by injection of the vectors into the aortic root with brief balloon occlusion above the sinuses, while at the same time prolonging diastole and vasodilating with acetylcholine (ACh) to maximize coronary exposure. Methods and Results—After incubation with albumin-coated perfluorocarbon microbubbles, an adenovirus encoding a reporter gene was infused into the aortic root of rats. To maximize delivery, the aortic root was transiently occluded with a balloon catheter during a brief ACh-induced asystole. Ultrasound was used to image the delivery and disrupt the microbubbles. Aortic occlusion with concomitant ACh increased myocardial gene expression for virus + microbubbles by >2.5-fold, from 925±165 to 2358±376 relative units (RU;P <0.01). This delivery system also produced substantial expression with vector alone (1473±549 RU). All uptakes were significant compared with 433±332 RU without virus. Conclusions—An adenoviral delivery system combining echo contrast with a catheter-based technique to maximize coronary perfusion increases gene delivery compared with echo contrast alone. This novel method permits efficient percutaneous gene delivery in closed-chest animals.

[1]  U. Schmidt,et al.  Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum Ca2+-ATPase in a Rat Model of Heart Failure , 2001, Circulation.

[2]  G Van Camp,et al.  Destruction of Contrast Microbubbles by Ultrasound: Effects on Myocardial Function, Coronary Perfusion Pressure, and Microvascular Integrity , 2001, Circulation.

[3]  S. Emani,et al.  Cardiac Gene Delivery With Cardiopulmonary Bypass , 2001, Circulation.

[4]  E. Unger,et al.  Gene Delivery Using Ultrasound Contrast Agents , 2001, Echocardiography.

[5]  T. Porter,et al.  Therapeutic Ultrasound for Gene Delivery , 2001, Echocardiography.

[6]  R V Shohet,et al.  Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. , 2000, Circulation.

[7]  M. Seyfarth,et al.  Enhanced cardiac contractility after gene transfer of V2 vasopressin receptors In vivo by ultrasound-guided injection or transcoronary delivery. , 2000, Circulation.

[8]  U. Schmidt,et al.  Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. , 2000, Circulation.

[9]  P. Boekstegers,et al.  Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins , 2000, Gene Therapy.

[10]  J. Guerrero,et al.  Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Isner,et al.  Catheter-based myocardial gene transfer utilizing nonfluoroscopic electromechanical left ventricular mapping. , 1999, Journal of the American College of Cardiology.

[12]  T C Skalak,et al.  Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. , 1998, Circulation.

[13]  T C Skalak,et al.  Direct In Vivo Visualization of Intravascular Destruction of Microbubbles by Ultrasound and Its Local Effects on Tissue. , 1998, Circulation.

[14]  J. Guerrero,et al.  Modulation of ventricular function through gene transfer in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Marbán,et al.  Ultrarapid, highly efficient viral gene transfer to the heart. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Kaul,et al.  Interactions between microbubbles and ultrasound: in vitro and in vivo observations. , 1997, Journal of the American College of Cardiology.

[17]  A. Watanabe Cholinoceptor-Activating & Cholinesterase-Inhibiting Drugs , 1992 .